How is the Adc Therapeutics SA today?

The Adc Therapeutics SA today is trading in the down by -8.37% at 1.97.

How has Adc Therapeutics SA performed historically?

The Adc Therapeutics SA is currently trading down -8.37% on an intraday basis in the past week the index rose 49.24%. The index has been up 17.96% in the past quarter and fell -52.07% in the past year. You can view this in the overview section.

What is Adc Therapeutics SA Annual Revenue?

Adc Therapeutics SA Annual Revenue rose 1.84%, in the last year to $70.84 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Adc Therapeutics SA Annual Net Profit?

Adc Therapeutics SA Annual Net Profit rose 34.25% in the last year to $157.85 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Adc Therapeutics SA Price to Earning Ratio?

Adc Therapeutics SA Price to Earning Ratio is -1.3, which is negative.

What is Adc Therapeutics SA Stock Price?

Adc Therapeutics SA Stock Price fell 52.07% and underperformed its sector by 63.4% in the past year.

What is Adc Therapeutics SA Quarterly Revenue?

Adc Therapeutics SA Quarterly Revenue rose 27.59% YoY to $23.03 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Adc Therapeutics SA Quarterly Net profit?

Adc Therapeutics SA Quarterly Net profit rose 17.17% YoY to $38.6 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is Adc Therapeutics SA Mutual Fund Holding?

Adc Therapeutics SA Mutual Fund Holding decreased by 0.45% in the last quarter to 11.08.

What is Adc Therapeutics SA Interest Coverage Ratio?

Adc Therapeutics SA Interest Coverage Ratio is -2.11, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Adc Therapeutics SA Institutional Holding?

Adc Therapeutics SA Institutional Holding decreased by 1.04% in the last quarter to 55.9.

Adc Therapeutics SA XNYS: ADCT

Adc Therapeutics SA Live Share Price Today, Share Analysis and Chart

Name: Adc Therapeutics SA: Is Infosys Ltd. worth buying?
Item: Adc Therapeutics SA
Rating: 1.57050
Author: Trendlyne DVM scores

about

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and ma...

1.97 -0.18 (-8.37%)

52.76% Fall from 52W High

730.9K XNYS Volume

XNYS 21 May, 2025 5:30 PM (EDT)

Board Meeting

The latest board meeting for Adc Therapeutics SA took place on 21 May 2025, for the purpose of RBC Capital Markets Global Healthcare Conference See details

Not Eligible

Expensive Valuation

11.5 / 100

Technically Neutral

51.3 / 100

1Yr Price target upside is 316%

5 analysts

Adc Therapeutics SA Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Adc Therapeutics SA Live Share Price Today, Share Analysis and Chart

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and ma...

52.76% Fall from 52W High

SWOT Analysis

Adc Therapeutics SA Live Price Chart

Adc Therapeutics SA FAQ

How is Adc Therapeutics SA today?

Adc Therapeutics SA today is trading in the red, and is down by -8.37% at 1.97.

How has Adc Therapeutics SA performed historically?

Adc Therapeutics SA is currently trading down -8.37% on an intraday basis. In the past week the stock rose 49.24%. stock has been up 17.96% in the past quarter and fell -52.07% in the past year. You can view this in the overview section.